Pages that link to "Q39244446"
Jump to navigation
Jump to search
The following pages link to Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts (Q39244446):
Displaying 50 items.
- Haploidentical Stem Cell Transplantation in Adult Haematological Malignancies (Q26745527) (← links)
- Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies (Q26751959) (← links)
- Evaluation of current cancer immunotherapy: hemato-oncology (Q27006179) (← links)
- Chimeric antigen receptor therapy for cancer (Q27013599) (← links)
- Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignancies (Q27014857) (← links)
- Targeting the innate immune system as immunotherapy for acute myeloid leukemia (Q27015876) (← links)
- T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome (Q28072227) (← links)
- Hematopoietic Stem Cells in Regenerative Medicine: Astray or on the Path? (Q28072887) (← links)
- Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission (Q28305230) (← links)
- Nonmyeloablative therapy and allogeneic hematopoietic stem cell transplantation (Q30311012) (← links)
- Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose (Q30558271) (← links)
- Case-control study of fetal microchimerism and breast cancer (Q33322513) (← links)
- A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma (Q33342339) (← links)
- Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies (Q33342453) (← links)
- Chronic graft-versus-host disease: Pathogenesis and clinical management. (Q33371639) (← links)
- Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial (Q33411822) (← links)
- Re-adapting T cells for cancer therapy: from mouse models to clinical trials (Q33588711) (← links)
- Immunotherapy in hematologic malignancies: past, present, and future (Q33593865) (← links)
- A history of haemopoietic cell transplantation (Q33610841) (← links)
- Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation (Q33642419) (← links)
- From autoimmunity to stem cell transplantation (Q33706249) (← links)
- Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience (Q33763908) (← links)
- Autologous bone marrow transplantation in acute leukemia (Q33769677) (← links)
- Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy (Q33769702) (← links)
- Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms (Q33771667) (← links)
- Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality (Q33788194) (← links)
- Post-transplant immunotherapy designed to prevent cancer recurrence (Q33788224) (← links)
- Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006. (Q33841129) (← links)
- Lymphokines post autologous peripheral blood stem cell transplantation in children (Q33847106) (← links)
- Histopathological changes in the liver after allogeneic bone marrow transplantation (Q33847992) (← links)
- Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation (Q33895386) (← links)
- Conditioning regimens for hematopoietic cell transplantation: one size does not fit all (Q33917170) (← links)
- Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells (Q33931811) (← links)
- High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation (Q33941128) (← links)
- Reconstitution of self-tolerance after hematopoietic stem cell transplantation (Q33945960) (← links)
- Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. (Q33967995) (← links)
- Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor (Q33986118) (← links)
- Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation? (Q33994342) (← links)
- Management of graft-versus-host disease in paediatric bone marrow transplant recipients (Q33999149) (← links)
- Principles of adoptive T cell cancer therapy (Q34003932) (← links)
- Advances in graft-versus-host disease biology and therapy (Q34031916) (← links)
- The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission (Q34033852) (← links)
- Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited (Q34065058) (← links)
- Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy (Q34089112) (← links)
- Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century (Q34105976) (← links)
- Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect (Q34107836) (← links)
- Stem-cell transplantation for inherited immunodeficiency disorders (Q34114571) (← links)
- Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation (Q34124707) (← links)
- Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT). (Q34135678) (← links)
- Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigens. (Q34140624) (← links)